A Pharmacokinetic and Safety Study of MY008211A Tablets in Subjects With Impaired or Normal Hepatic Function
Clinical trial NCT07625618 · COMPLETED
Trial details
- NCT number
- NCT07625618
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-20
- Primary completion
- 2024-12-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.